Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Chytridiomycosis, an amphibian skin disease caused by the emerging fungal pathogen Batrachochytrium dendrobatidis, has been implicated in catastrophic global amphibian declines. The result is an alarming decrease in amphibian diversity that is a great concern for the scientific community. Clinical trials testing potential antifungal drugs are needed to identify alternative treatments for amphibians infected with this pathogen. In this study, we quantified the MICs of chloramphenicol (800 μg/ml), amphotericin B (0.8 to 1.6 μg/ml), and itraconazole (Sporanox) (20 ng/ml) against B. dendrobatidis. Both chloramphenicol and amphotericin B significantly reduced B. dendrobatidis infection in naturally infected southern leopard frogs (Rana [Lithobates] sphenocephala), although neither drug was capable of complete fungal clearance. Long-term exposure of R. sphenocephala to these drugs did not inhibit antimicrobial peptide (AMP) synthesis, indicating that neither drug is detrimental to this important innate skin defense. However, we observed that chloramphenicol, but not amphotericin B or itraconazole, inhibited the growth of multiple R. sphenocephala skin bacterial isolates in vitro at concentrations below the MIC against B. dendrobatidis. These results indicate that treatment with chloramphenicol might dramatically alter the protective natural skin microbiome when used as an antifungal agent. This study represents the first examination of the effects of alternative antifungal drug treatments on amphibian innate skin defenses, a crucial step to validating these treatments for practical applications.
Baitchman,
Pathogenesis, diagnosis, and treatment of amphibian chytridiomycosis.
2013, Pubmed,
Xenbase
Baitchman,
Pathogenesis, diagnosis, and treatment of amphibian chytridiomycosis.
2013,
Pubmed
,
Xenbase Becker,
Cutaneous bacteria of the redback salamander prevent morbidity associated with a lethal disease.
2010,
Pubmed Berger,
Chytridiomycosis causes amphibian mortality associated with population declines in the rain forests of Australia and Central America.
1998,
Pubmed Berger,
Life cycle stages of the amphibian chytrid Batrachochytrium dendrobatidis.
2005,
Pubmed Berger,
Treatment of chytridiomycosis requires urgent clinical trials.
2010,
Pubmed Berger,
A zoospore inhibition technique to evaluate the activity of antifungal compounds against Batrachochytrium dendrobatidis and unsuccessful treatment of experimentally infected green tree frogs (Litoria caerulea) by fluconazole and benzalkonium chloride.
2009,
Pubmed Bishop,
Elimination of the amphibian chytrid fungus Batrachochytrium dendrobatidis by Archey's frog Leiopelma archeyi.
2009,
Pubmed Bland,
Multiple significance tests: the Bonferroni method.
1995,
Pubmed Bland,
The use of transformation when comparing two means.
1996,
Pubmed Boyle,
Rapid quantitative detection of chytridiomycosis (Batrachochytrium dendrobatidis) in amphibian samples using real-time Taqman PCR assay.
2004,
Pubmed Brannelly,
Clinical trials with itraconazole as a treatment for chytrid fungal infections in amphibians.
2012,
Pubmed Brucker,
Amphibian chemical defense: antifungal metabolites of the microsymbiont Janthinobacterium lividum on the salamander Plethodon cinereus.
2008,
Pubmed Conlon,
Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.
1999,
Pubmed Conlon,
Dermal cytolytic peptides and the system of innate immunity in anurans.
2009,
Pubmed el-Mofty,
Induction of leukaemia in chloramphenicol-treated toads.
2000,
Pubmed Fisher,
Emerging fungal threats to animal, plant and ecosystem health.
2012,
Pubmed GALE,
The assimilation of amino-acids by bacteria. XV. Actions of antibiotics on nucleic acid and protein synthesis in Staphylococcus aureus.
1953,
Pubmed Gallis,
Amphotericin B: 30 years of clinical experience.
1990,
Pubmed Gammill,
Norepinephrine depletion of antimicrobial peptides from the skin glands of Xenopus laevis.
2012,
Pubmed
,
Xenbase Garner,
Using itraconazole to clear Batrachochytrium dendrobatidis infection, and subsequent depigmentation of Alytes muletensis tadpoles.
2009,
Pubmed Gray,
Amphotericin primarily kills yeast by simply binding ergosterol.
2012,
Pubmed Holden,
Nikkomycin Z is an effective inhibitor of the chytrid fungus linked to global amphibian declines.
2014,
Pubmed
,
Xenbase Inselmann,
Comparison of the effects of liposomal amphotericin B and conventional amphotericin B on propafenone metabolism and hepatic cytochrome P-450 in rats.
2000,
Pubmed Jones,
Treatment of chytridiomycosis with reduced-dose itraconazole.
2012,
Pubmed Kindermann,
Urinary corticosterone metabolites and chytridiomycosis disease prevalence in a free-living population of male Stony Creek frogs (Litoria wilcoxii).
2012,
Pubmed Kriger,
Techniques for detecting chytridiomycosis in wild frogs: comparing histology with real-time Taqman PCR.
2006,
Pubmed Laniado-Laborín,
Amphotericin B: side effects and toxicity.
2009,
Pubmed Le Guennec,
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
1995,
Pubmed Leyden,
Pharmacokinetics and pharmacology of terbinafine and itraconazole.
1998,
Pubmed Lips,
Emerging infectious disease and the loss of biodiversity in a Neotropical amphibian community.
2006,
Pubmed Manikandan,
Data transformation.
2010,
Pubmed Marcum,
Effects of Batrachochytrium dendrobatidis infection on ion concentrations in the boreal toad Anaxyrus (Bufo) boreas boreas.
2010,
Pubmed Martel,
Developing a safe antifungal treatment protocol to eliminate Batrachochytrium dendrobatidis from amphibians.
2011,
Pubmed McClanahan,
Rate of water uptake through the integument of the desert toad, Bufo punctatus.
1969,
Pubmed Muijsers,
Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus's egg?
2012,
Pubmed Osherov,
Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14alpha-demethylase gene, pdmA.
2001,
Pubmed Page,
Chloramphenicol 1. Hazards of use and the current regulatory environment.
1991,
Pubmed Panda,
Itraconazole - a potent antifungal drug.
1997,
Pubmed Parker,
Clinical diagnosis and treatment of epidermal chytridiomycosis in African clawed frogs (Xenopus tropicalis).
2002,
Pubmed
,
Xenbase Pask,
Skin peptides protect juvenile leopard frogs (Rana pipiens) against chytridiomycosis.
2013,
Pubmed Pennisi,
Amphibian decline. Life and death play out on the skins of frogs.
2009,
Pubmed Pessier,
Cutaneous chytridiomycosis in poison dart frogs (Dendrobates spp.) and White's tree frogs (Litoria caerulea).
1999,
Pubmed Peterson,
Host stress response is important for the pathogenesis of the deadly amphibian disease, Chytridiomycosis, in Litoria caerulea.
2013,
Pubmed Pfaller,
In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species.
2008,
Pubmed Pinjon,
Molecular mechanisms of itraconazole resistance in Candida dubliniensis.
2003,
Pubmed Pounds,
Widespread amphibian extinctions from epidemic disease driven by global warming.
2006,
Pubmed Ramsey,
Immune defenses against Batrachochytrium dendrobatidis, a fungus linked to global amphibian declines, in the South African clawed frog, Xenopus laevis.
2010,
Pubmed
,
Xenbase Rollins-Smith,
Antimicrobial peptide defenses of the mountain yellow-legged frog (Rana muscosa).
2006,
Pubmed Rollins-Smith,
Antimicrobial peptide defenses against chytridiomycosis, an emerging infectious disease of amphibian populations.
2005,
Pubmed Rollins-Smith,
The role of amphibian antimicrobial peptides in protection of amphibians from pathogens linked to global amphibian declines.
2009,
Pubmed Rollins-Smith,
Antimicrobial peptide defenses against pathogens associated with global amphibian declines.
2002,
Pubmed Rollins-Smith,
Antimicrobial peptide defenses of the Tarahumara frog, Rana tarahumarae.
2002,
Pubmed ROSENTHAL,
BONE-MARROW HYPOPLASIA FOLLOWING USE OF CHLORAMPHENICOL EYE DROPS.
1965,
Pubmed Roth,
Bacterial flora on Cascades frogs in the Klamath mountains of California.
2013,
Pubmed Schloegel,
Two amphibian diseases, chytridiomycosis and ranaviral disease, are now globally notifiable to the World Organization for Animal Health (OIE): an assessment.
2010,
Pubmed Shadomy,
Light sensitivity of prepared solutions of amphotericin B.
1973,
Pubmed Simmaco,
Antimicrobial peptides from amphibian skin: what do they tell us?
1998,
Pubmed Smith,
Measurement of protein using bicinchoninic acid.
1985,
Pubmed Stevens,
Contributions of microbes in vertebrate gastrointestinal tract to production and conservation of nutrients.
1998,
Pubmed Thummel,
In vitro and in vivo drug interactions involving human CYP3A.
1998,
Pubmed Venkateswarlu,
Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance.
1996,
Pubmed Voyles,
Pathogenesis of chytridiomycosis, a cause of catastrophic amphibian declines.
2009,
Pubmed Voyles,
Electrolyte depletion and osmotic imbalance in amphibians with chytridiomycosis.
2007,
Pubmed Wake,
Colloquium paper: are we in the midst of the sixth mass extinction? A view from the world of amphibians.
2008,
Pubmed Woodhams,
Treatment of amphibians infected with chytrid fungus: learning from failed trials with itraconazole, antimicrobial peptides, bacteria, and heat therapy.
2012,
Pubmed
,
Xenbase Young,
Chloramphenicol with fluid and electrolyte therapy cures terminally ill green tree frogs (Litoria caerulea) with chytridiomycosis.
2012,
Pubmed
